KRAS and non-small cell lung carcinoma: KRAS mutations, that mainly occur in codon 12 (13% of NSCLC), 13 and 61, determine a loss of intrinsic GTPase activity with subsequent effects on cell proliferation signals and tumourigenesis (26).